US 12266425
T cell receptor sequences diagnostic for COVID-19 and related compositions
granted A61KA61K2039/57A61K40/11
Quick answer
US patent 12266425 (T cell receptor sequences diagnostic for COVID-19 and related compositions) held by Adaptive Biotechnologies Corporation expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Adaptive Biotechnologies Corporation
- Grant date
- Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/57, A61K40/11, A61K40/32, A61K40/46